RO Toolbox is a clinical reference app for radiation oncologists, providing dose calculators and practice guidelines on iOS and Android.
The App DNA
What makes this app unique?
The platform removes the friction of searching disparate clinical references during point-of-care delivery, serving as a consolidated, evidence-based utility for practitioners.
For Radiation oncology health care professionals requiring point-of-care clinical references and evidence-based practice tools.
What does it look like?
Key features
Point-of-care tools for calculating dose constraints and toxicity scales.
Compiled evidence-based references for radiation oncology delivery.
Direct interface for users to access support and identify funding opportunities.
How much does it cost?
The app operates as a non-profit resource funded by the Radiation Oncology Institute, prioritizing professional distribution over direct monetization.
Velocity
Maintenance developmentmonetizationUX improvementsShow more...
RO Toolbox operates on a maintenance cadence, having shipped only three distinct versions over the last six months. The latest release, which arrived two days ago, introduced support and funding features after a significant gap since the previous update in April. Development appears focused on occasional feature additions rather than a consistent or high-frequency release schedule. The current cadence reflects a stable but infrequent update pattern.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate the core application experience provides high utility and satisfaction for long-term users since initial launch.
How are ratings & reviews evolving?
What users say, by theme
- The core application experience provides high utility and satisfaction for long-term users since initial launch
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for RO Toolbox
How's the Medical market?
RO Toolbox serves a niche professional audience, maintaining a 4.5-star rating across a small user base. The lack of direct monetization signals a focus on institutional influence rather than consumer-scale revenue.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for RO Toolbox
Where is it heading?
The radiation oncology reference market is consolidating around tools that offer direct institutional integration. RO Toolbox is well-positioned to leverage its non-profit status, but must accelerate its update cadence to ensure clinical guidelines remain current.
- The latest release introduces in-app funding mechanisms, which creates a new B2B utility layer for the professional user base.
- A five-month release gap prior to the latest update suggests a maintenance-mode cadence that could jeopardize clinical data accuracy.
The SWOT
- Non-profit funding model removes paywalls
- Category authority via ASTRO Foundation backing
- B2B grant pipeline integration
Next best moves
Audit clinical guideline library because the five-month inactivity gap risks data staleness → maintain professional trust
+ 1 more prioritized moveThe counter-intuitive read
The non-profit status is a competitive advantage, not a weakness…
Read the full takeBottom line
RO Toolbox maintains professional authority through its non-profit focus, but the recent five-month release gap threatens its utility as a point-of-care reference; prioritizing clinical data validation will ensure the tool remains a primary resource for radiation oncologists.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated